|
|
Other links at Articles > HIV/AIDS |
| 2. |
Maraviroc Safe, Effective for Previously Treated Patients With R5 HIV-1 Infection
|
|
|
Maraviroc reduces viral load and improves CD4 cell counts when added to optimized background therapy in treatment-experienced patients infected with R5 HIV-1, according to the results of two multinational phase III clinical trials reported in the October 2 issue of The New England Journal of Medicine. Reuters Health Information
|
| 3. |
HIV Prevalence in US Tops 1 Million
|
|
|
The US Centers for Disease Control and Prevention estimate that approximately 1.1 million adults and adolescents in the US were living with HIV infection at the end of 2006, according to an article in the Morbidity and Mortality Weekly Report for October 3. Reuters Health Information
|
|
|